The Cognitive and Clinical Neuroimaging Core (CCNC), established in 2008, is dedicated to studying the relationship between symptoms of psychiatric disorders and substance use, and the ways in which we think, solve problems, and process information. Through the use of various magnetic resonance imaging (MRI) techniques and neuropsychological, clinical, and diagnostic instruments, our goal is to identify risk factors for mental illness and substance use. In particular, our studies focus on altered executive functioning, differential patterns of brain activation, and changes in the brain’s white matter, which plays a critical role in the communication of information between brain regions.
Primarily, we are interested in examining the brain as it relates to marijuana use and bipolar disorder, as well as study the trajectory of brain development in healthy adolescents and adults. Further, we collaborate with several investigators on studies related to a variety of disorders including depression, non-suicidal self- injury, and borderline personality disorder.